The impact of obesity on outcomes in patients receiving extracorporeal life support. Issue 11 (22nd July 2020)

• Record Type: Journal Article
• Authors: Christian‐Miller, Nathaniel; Hadaya, Joseph; Nakhla, Morcos; Sanaiha, Yas; Madrigal, Josef; Emami, Sara; Cale, Mario; Sareh, Sohail; Benharash, Peyman
• Is Part Of: Artificial organs. Volume 44:Issue 11(2020)
• Page Start: 1184
• Page End: 1191
• Publication Date: 2020-07-22
• Subjects: cardiopulmonary failure -- complications -- extracorporeal life support -- mortality -- obesity -- readmissions -- respiratory failure; Artificial organs -- Periodicals; 617.956
• DOI: 10.1111/aor.13752
• Languages: English
• ISSNs: 0160-564X

Abstract

Abstract: Extracorporeal life support (ECLS) has been increasingly utilized to manage cardiac and pulmonary dysfunction. The impact of obesity on outcomes of ECLS is poorly defined. The purpose of the study was to compare in‐hospital mortality, resource use, complications, and readmissions in obese versus non‐obese patients receiving ECLS. We performed a retrospective cohort study of all adult ECLS patients with and without an obesity diagnosis using the 2010–2016 Nationwide Readmissions Database (NRD). Mortality, length of stay (LOS), hospital charges, complications, and readmissions were evaluated using multivariable logistic and linear regression. Of 23 876, patients who received ECLS, 1924 (8.1%) were obese. Obese patients received ECLS more frequently for respiratory failure (29.5% vs. 23.7%, P = .001). After adjustment for patient and hospital factors, obesity was not associated with increased odds of mortality (AOR = 1.06, P = .44) and was associated with decreased LOS (13.7 vs. 21.2 days, P < .001), hospital charges ($171 866 vs. $211 445, P < .001), and 30‐day readmission (AOR = 0.71, P = .03). Obesity was also associated with reduced odds of hemorrhage (AOR = 0.43, P < .001), neurologic complications (AOR = 0.55, P = .004), and acute kidney injury (AOR=0.83, P = .04). After stratification by ECLS indication, obesity remained predictive of shorter LOS (AOR range: 0.53‐0.78, all P < .05 ) and did not impact mortality (all P > .05). Respiratory support remains the most common indication for ECLS among obese patients. Among all patients, as well as by individual ECLS indication, obesity was not associated with increased odds of mortality. These findings suggest that obesity should not be considered a high‐risk contraindication to ECLS.